group-women-sports-teams

News & Media

Take a look inside our world

Press Releases



Teva Announces Collaboration to Commercialize Formycon’s Biosimilar Candidate to Eylea® (aflibercept) in major parts of Europe and in Israel


Teva and Samsung Bioepis Enter into a Strategic Partnership for Commercialization of EPYSQLI® (eculizumab-aagh) in the United States


Teva to Present at the 43rd Annual J.P. Morgan Healthcare Conference


Teva to Host Conference Call to Discuss Fourth Quarter and Full Year 2024 Financial Results and 2025 Financial Guidance at 8 a.m. ET on January 29, 2025


Teva and Sanofi Announce Duvakitug (Anti-TL1A) Positive Phase 2b Results Demonstrating Best-in-Class Potential in Ulcerative Colitis and Crohn’s Disease


Teva Announces New Patient Access Program with Direct Relief to Provide Access to Inhalers for Uninsured Patients


Teva Announces New Patient Access Program with Direct Relief


Teva Announces Agreement to Divest Teva-Takeda, its Business Venture in Japan


Teva Announces Agreement to Divest Teva-Takeda, its Business Venture in Japan


Teva Presents Positive Efficacy and Safety Data of AJOVY® (fremanezumab) for the Prevention of Episodic Migraine in Children and Adolescents from Phase 3 SPACE Trial
View all press releases

Feature stories


Teva scientist working on duvakitug in lab

Addressing the unmet needs of Inflammatory Bowel Disease patients

Konstantina Katcheves, SVP Innovative Business Development

3 Trends

3 Trends I’m Watching in Pharma Business Development

Navdeep Boparai

"I have learned more from ‘successful failures’ than clear-cut wins"

Irit Hovich, Global I&D Lead at Teva

“We All Deserve to Feel Like We Belong”


3 Trends I’m Watching in Clinical Research Studies


Where Big Pharma Meets Academia: Key Trends I’m Watching

Placid Jover with Teva’s Spanish HR and payroll team

“Real Progress Comes Not from Extraordinary Moments but from the Everyday”


Why Diversity in Clinical Trials is So Important

Alyssa Fenoglio

3 Trends I’m Watching in Pharmaceutical Marketing and Digital


Living With an Invisible Disability: What We All Need to Know
View all stories

Contacts for Media Inquiries

Kelley Dougherty

North America

+1-973-658-0237
Kelley.Dougherty@tevapharm.com

Eden Klein

Israel & Corporate

+972-3-9062645
Eden.Klein@teva.co.il

Fiona Cohen

Europe

fiona.cohen@tevaeu.com

Teva Media Assets

These proprietary media assets are available for download and are intended for non-commercial media use and research only.

Download Logo Download Teva B-Roll

Connect with us on social media

Follow us on Facebook

Go to facebook.com

Follow us on Linkedin

Go to linkedin.com

Follow us on Twitter

Go to twitter.com